320
Participants
Start Date
April 10, 2005
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2015
Risk-stratified therapy
Dose-dense intensive chemotherapy and high dose of Ara-C in the consolidation therapy.
InstituteHBDH, Tianjin
Institute of Hematology & Blood Diseases Hospital, China
OTHER